Literature DB >> 12077254

Unraveling of the polymorphic C lambda 2-C lambda 3 amplification and the Ke+Oz- polymorphism in the human Ig lambda locus.

Mirjam van der Burg1, Barbara H Barendregt, Ellen J van Gastel-Mol, Talip Tümkaya, Anton W Langerak, Jacques J M van Dongen.   

Abstract

Two polymorphisms of the human Ig(lambda) (IGL) locus have been described. The first polymorphism concerns a single, 2- or 3-fold amplification of 5.4 kb of DNA in the C(lambda)2-C(lambda)3 region. The second polymorphism is the Mcg(-)Ke(+)Oz(-) isotype, which has only been defined via serological analyses in Bence-Jones proteins of multiple myeloma patients and was assumed to be encoded by a polymorphic C(lambda)2 segment because of its high homology with the Mcg(-)Ke(-)Oz(-) C(lambda)2 isotype. It has been speculated that the Mcg(-)Ke(+)Oz(-) isotype might be encoded by a C(lambda) gene segment of the amplified C(lambda)2-C(lambda)3 region. We now unraveled both IGL gene polymorphisms. The amplification polymorphism appeared to result from a duplication, triplication, or quadruplication of a functional J-C(lambda)2 region and is likely to have originated from unequal crossing over of the J-C(lambda)2 and J-C(lambda)3 region via a 2.2-kb homologous repeat. The amplification polymorphism was found to result in the presence of one to five extra functional J-C(lambda)2 per genome regions, leading to decreased Ig(kappa):Ig(lambda) ratios on normal peripheral blood B cells. Via sequence analysis, we demonstrated that the Mcg(-)Ke(+)Oz(-) isotype is encoded by a polymorphic C(lambda)2 segment that differs from the normal C(lambda)2 gene segment at a single nucleotide position. This polymorphism was identified in only 1.5% (2 of 134) of individuals without J-C(lambda)2 amplification polymorphism and was not found in the J-C(lambda)2 amplification polymorphism of 44 individuals, indicating that the two IGL gene polymorphisms are not linked.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077254     DOI: 10.4049/jimmunol.169.1.271

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Segmental duplications and copy-number variation in the human genome.

Authors:  Andrew J Sharp; Devin P Locke; Sean D McGrath; Ze Cheng; Jeffrey A Bailey; Rhea U Vallente; Lisa M Pertz; Royden A Clark; Stuart Schwartz; Rick Segraves; Vanessa V Oseroff; Donna G Albertson; Daniel Pinkel; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2005-05-25       Impact factor: 11.025

2.  A comprehensive profile of DNA copy number variations in a Korean population: identification of copy number invariant regions among Koreans.

Authors:  Jae Pil Jeon; Sung Mi Shim; Jong Sun Jung; Hye Young Nam; Hye Jin Lee; Berm Seok Oh; Kuchan Kim; Hyung Lae Kim; Bok Ghee Han
Journal:  Exp Mol Med       Date:  2009-09-30       Impact factor: 8.718

3.  Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats.

Authors:  John A L Armour; Raquel Palla; Patrick L J M Zeeuwen; Martin den Heijer; Joost Schalkwijk; Edward J Hollox
Journal:  Nucleic Acids Res       Date:  2006-12-14       Impact factor: 16.971

4.  Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment?

Authors:  I Rebollo-Mesa; E Nova-Lamperti; P Mobillo; M Runglall; S Christakoudi; S Norris; N Smallcombe; Y Kamra; R Hilton; S Bhandari; R Baker; D Berglund; S Carr; D Game; S Griffin; P A Kalra; R Lewis; P B Mark; S Marks; I Macphee; W McKane; M G Mohaupt; R Pararajasingam; S P Kon; D Serón; M D Sinha; B Tucker; O Viklický; R I Lechler; G M Lord; M P Hernandez-Fuentes
Journal:  Am J Transplant       Date:  2016-08-08       Impact factor: 8.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.